Answer
Women should not breastfeed during tafasitamab treatment or for at least 3 months after the last dose.
Sources for this answer
- MINJUVI 200 mg powder for concentrate for solution for infusionIncyte Biosciences UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked